TT Electronics to Spotlight its Radwave Technologies Collaboration at MD&M Minneapolis with Demo of New Electromagnetic Platform for Surgical Navigation

TT will also feature its core specialties for the medical device industry, including high reliability sensor, power and connectivity technologies, and global manufacturing

TT Electronics, a global provider of engineered technologies for performance-critical applications, will be exhibiting at MD&M Minneapolis 2021, November 3-4 in Minneapolis, Minnesota.

TT will showcase its collaboration with Radwave Technologies, bringing to market an innovative electromagnetic (EM) tracking platform for surgical navigation. The platform is customizable to enable accurate tracking of a broad spectrum of minimally invasive diagnostic and therapeutic devices during surgical procedures with no clear line of sight.

This advanced technology offers solutions for medical device innovators that are seeking to add new or improved EM capabilities to their medical products. Demonstrations will be available at TT’s booth #1608. TT will also highlight its core specialties, reflecting the company’s strategic focus on sustainability and developing technology solutions that enable a cleaner, smarter, healthier future:

●        Medical grade power supplies and solutions – reliable power conversion and management to drive product performance while maintaining efficiency and safety; these include miniaturized coils, transformers, and inductors uniquely developed for implantable devices and surgical navigation in clinical care, therapy and well-being, and home healthcare environments

●        Smart sensors and passive components – designed to capture data, inform decisions, support data analytics, and enable artificial intelligence; these include non-contact, Hall effect sensors, infrared optical switches and arrays for detection of objects or fluids, and fixed and variable resistors for current sensing, power management, and signal conditioning

●        Connectivity Solutions – built to connect, sense, track, and monitor, including wearable IoT devices, and wireless devices communicating over GSM and LTE Cat M1/NB-IoT for use in fast-paced healthcare and pharmaceutical environments

●        End-to-end, low-volume, high-mix global manufacturing in FDA-registered facilities – offerings span engineering, test development, system integration and fulfilment services for imaging/nuclear and monitoring equipment, diagnostic instruments, and cardiology and electrosurgical devices

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version